Sofosbuvir/Ledipasvir (SOF/LDV) has been approved by the European Medicine Agency (EMA) for the treatment of children and adolescents (at least 3 years of age) with chronic hepatitis C (CHC) genotype 1, 3, and 4 infection. The aim of this study was to evaluate the efficacy and safety of SOF/LDV in adolescents (12 to <18 years old) with CHC in the real-world setting.

Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4: A Real-world Study / Serranti, D., Nebbia, G., Cananzi, M., Nicastro, E., Di Dato, F., Nuti, F., Garazzino, S., Silvestro, E., Giacomet, V., Forlanini, F., Pinon, M., Calvo, P.L., Riva, S., Dodi, I., Cangelosi, A.M., Antonucci, R., Ricci, S., Bartolini, E., Mastrangelo, G., Trapani, S., et al.. - In: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. - ISSN 0277-2116. - ELETTRONICO. - Publish Ahead of Print:(2020), pp. 0-0. [10.1097/MPG.0000000000002900]

Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4: A Real-world Study

Serranti, Daniele;Garazzino, Silvia;Dodi, Icilio;Ricci, Silvia;Bartolini, Elisa;Mastrangelo, Greta;Trapani, Sandra;Lenge, Matteo;Indolfi, Giuseppe
2020

Abstract

Sofosbuvir/Ledipasvir (SOF/LDV) has been approved by the European Medicine Agency (EMA) for the treatment of children and adolescents (at least 3 years of age) with chronic hepatitis C (CHC) genotype 1, 3, and 4 infection. The aim of this study was to evaluate the efficacy and safety of SOF/LDV in adolescents (12 to <18 years old) with CHC in the real-world setting.
2020
Publish Ahead of Print
0
0
Goal 3: Good health and well-being for people
Serranti, Daniele; Nebbia, Gabriella; Cananzi, Mara; Nicastro, Emanuele; Di Dato, Fabiola; Nuti, Federica; Garazzino, Silvia; Silvestro, Erika; Giacom...espandi
1a - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
J pediatr gastroenterol nutr - 2020 - Serranti - Efficacy of Sofosbuvir Ledipasvir in Adolescents With Chronic Hepatitis.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 100.39 kB
Formato Adobe PDF
  Richiedi una copia all'autore
100.39 kB Adobe PDF   Richiedi una copia all'autore

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1210527
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 19
social impact